Published in Schweiz Med Wochenschr on September 19, 1987
Erythropoietin: the developing story. Br Med J (Clin Res Ed) (1988) 1.05
Acute parathyroid hormone response to epinephrine in vivo. J Clin Invest (1973) 1.49
Nature and rate of vascular refilling during hemodialysis and ultrafiltration. Kidney Int (1992) 1.46
Recurrence of Fabry's disease in a renal allograft 14 years after transplantation. Nephrol Dial Transplant (1995) 1.38
Pancreatitis after renal transplantation. Gut (1975) 1.21
Human parathyroid hormone. Immunological characterization of antibodies against a glandular extract and the synthetic amino-terminal fragments 1-12 and 1-34 and their use in the determination of immunoreactive hormone in human sera. J Clin Invest (1974) 1.20
Thiosulphate-sulphur transferase (rhodanese) deficiency in Leber's hereditary optic atrophy. Lancet (1981) 1.11
Oxidative injury to erythrocytes, cell rigidity, and splenic hemolysis in hemodialyzed uremic patients. Ann Intern Med (1975) 1.05
[Plasmacytosis following thrombolytic streptokinase therapy]. Schweiz Med Wochenschr (1974) 1.05
Effect of human exogenous leukocyte interferon in cytomegalovirus infections. J Infect Dis (1976) 0.99
A blood protein monitor for the continuous measurement of blood volume changes during hemodialysis. Kidney Int (1990) 0.94
Pharmacokinetics and dosage adjustment of cefotiam in renal impaired patients. J Antimicrob Chemother (1984) 0.94
Renal pathology and premortem clinical presentation of Caucasian patients with AIDS: an autopsy study from the era prior to antiretroviral therapy. Swiss Med Wkly (2001) 0.93
Role of transferrin, Fe, and transferrin receptors in myeloid leukemia cell growth. Studies with an antitransferrin receptor monoclonal antibody. J Clin Invest (1985) 0.93
A long-term functioning human pancreatic islet allotransplant. Transplantation (1980) 0.90
Decreased thiosulfate sulfur transferase (rhodanese) in Leber's hereditary optic atrophy. Klin Wochenschr (1984) 0.90
Relation of cyclosporine blood levels to adverse effects on lipoproteins. Transplantation (1994) 0.89
[The "sarcoidosis-lymphoma syndrome"--a lymphocyte dysregulation?]. Pneumologie (1992) 0.89
Toxoplasmosis in hairy-cell leukaemia. Br J Haematol (1986) 0.86
Platelet aggregation and beta-thromboglobulin levels in nephrotic patients with and without thrombosis. Clin Nephrol (1981) 0.86
Stimulation of Na+/H+ exchange activity by endothelin in opossum kidney cells. Pflugers Arch (1995) 0.86
Metabolic aspects of phosphate replacement therapy for hypophosphatemia after renal transplantation: impact on muscular phosphate content, mineral metabolism, and acid/base homeostasis. Am J Kidney Dis (1999) 0.85
Transferrin receptor regulation is coupled to intracellular ferritin in proliferating and differentiating HL60 leukemia cells. J Cell Physiol (1985) 0.85
Peritonitis during continuous ambulatory peritoneal dialysis: improving patient defense by type of buffer of dialysate? Nephron (1981) 0.85
A randomized controlled clinical trial of topical photodynamic therapy with methyl aminolaevulinate in the treatment of actinic keratoses in transplant recipients. Br J Dermatol (2004) 0.85
[Calcium ion concentration in the serum. Findings in two age groups in both sexes; relation to the total calcium and the ultrafiltered calcium; results in dysfunction of the parathyroid glands]. Schweiz Med Wochenschr (1972) 0.85
Parathyroid hormone responses to catecholamines and to changes of extracellular calcium in cows. J Clin Invest (1978) 0.85
1,25-dihydroxyvitamin D3 stimulates transforming growth factor-beta1 synthesis by mouse renal proximal tubular cells. Kidney Blood Press Res (1999) 0.84
The acute parathyroid hormone response to changes in ionized calcium during phosphate infusions in the cow. Eur J Clin Invest (1973) 0.84
[Mycobacterioses in patients with HIV infection]. Dtsch Med Wochenschr (1988) 0.83
Differential use of cardiac troponin T versus I in hemodialysis patients. Clin Nephrol (2003) 0.83
CSF-responsive bone marrow cells in liquid culture: characterization and screening applications. Int J Cell Cloning (1986) 0.83
[Strongyloidiasis following kidney transplantation]. Schweiz Med Wochenschr (1978) 0.83
Human urinary fluoride excretion as influenced by renal functional impairment. Nephron (1980) 0.83
Diagnostic and prognostic value of RNA-proteolipid in sera of patients with malignant disorders following therapy: first clinical evaluation of a novel tumor marker. Cancer Res (1987) 0.83
Centrifugation of 50 ml of peritoneal fluid is sufficient for microbiological examination in continuous ambulatory peritoneal dialysis (CAPD) patients with peritonitis. Infection (1986) 0.81
Immunogenicity of a hepatitis B subunit vaccine in hemodialysis and in renal transplant recipients. Antiviral Res (1983) 0.81
Dialysis bone disease. A quantitative histologic study. Nephron (1974) 0.81
Reduced kidney transplant rejection rate and pharmacoeconomic advantage of mycophenolate mofetil. Nephrol Dial Transplant (1999) 0.81
Ectopic ACTH syndrome and medullary thyroid carcinoma. Acta Endocrinol (Copenh) (1977) 0.81
Post-transplant diabetes mellitus in renal allograft recipients: a matched-pair control study. Nephrol Dial Transplant (1990) 0.81
Is heparin therapy necessary in CAPD peritonitis? Perit Dial Int (1997) 0.80
[Pernicious anemia and gastric carcinoma (author's transl)]. Schweiz Rundsch Med Prax (1977) 0.80
Stimulation of erythropoietin in renal insufficiency by hypobaric hypoxia. Nephrol Dial Transplant (1992) 0.80
Interferon as an adjuvant for hepatitis B vaccination in non- and low-responder populations. Eur J Clin Microbiol (1984) 0.80
Prognosis in acquired aplastic anemia. Acta Haematol (1984) 0.80
[Cholelithiasis in primary hyperparathyroidism]. Schweiz Med Wochenschr (1974) 0.79
Unidirectional duodenal and jejunal calcium and phosphorus transport in the rat: effects of dietary phosphorus depletion, ethane-1-hydroxy-1,1-diphosphonate and 1,25 dihydroxycholecalciferol. Res Exp Med (Berl) (1989) 0.79
Hyperparathyroidism after kidney transplantation: a retrospective case controlled study. Klin Wochenschr (1991) 0.79
Parathyroid hormone response in newborn infants during exchange transfusion with blood supplemented with citrate and phosphate: effect of iv calcium. Pediatr Res (1979) 0.78
Tertiary hyperparathyroidism after cadaver-kidney transplantation. Transplant Proc (1984) 0.78
Thirty-two years of renal transplantation in Zurich. Clin Transpl (1996) 0.78
[Chronic myeloid leukemia: multivariant analysis of initial findings regarding its effect on mean life expectancy]. Schweiz Med Wochenschr (1985) 0.78
Should living related kidney transplantation be considered for patients with renal failure due to Fabry's disease? Nephrol Dial Transplant (1998) 0.78
[Juvenile diabetes, tapeto-retinal degeneration, neurogenic hearing disorder (Alström syndrome), associated with congenital dyserythropoietic type III anemia]. Schweiz Med Wochenschr (1977) 0.78
1,25-dihydroxyvitamin D3 and the synthetic vitamin D analogue, KH 1060, modulate the growth of mouse proximal tubular cells. Kidney Blood Press Res (1996) 0.78
Serum parathyroid hormone concentrations in vitamin D deficiency rickets of infancy: effects of intravenous calcium and vitamin D. Horm Metab Res (1973) 0.78
[Hairy-cell leukemia with osteolytic bone changes]. Schweiz Med Wochenschr (1977) 0.78
Calcium and inorganic phosphate secretion of rat ileum in vitro. Influence of uremia and 1,25 (OH)2D3 inhibition. Res Exp Med (Berl) (1988) 0.78
Suppression of ICAM-1 expression in renal proximal tubular cells by 1,25-dihydroxyvitamin D3. Kidney Blood Press Res (2001) 0.78
Acute parathyroid hormone response: sensitivity, relationship to hypocalcemia, and rapidity. Endocrinology (1974) 0.77
Role of codon 10 and codon 25 polymorphisms on TGF-beta 1 gene expression and protein synthesis in stable renal allograft recipients. Transplant Proc (2002) 0.77
Immunosuppressive treatment of pure red-cell aplasia. Lancet (1971) 0.77
Late complications after total hip replacement in renal allograft recipients. Int Orthop (1994) 0.77
Renal handling of fluoride in healthy man. Ren Physiol (1982) 0.77
Skin cancers in organ transplant recipients: two cases of virus-induced neoplasms. Dermatology (2001) 0.77
Irreversibility of cyclosporine-induced renal function impairment in heart transplant recipients. J Heart Lung Transplant (1993) 0.77
[Osteopathy in chronic kidney failure]. Dtsch Med Wochenschr (1971) 0.77
Pancreas rejection in combined pancreaticoduodenal and renal allotransplantation in man. Transplantation (1975) 0.77
Calcium ATPase and intestinal calcium transport in uremic rats. Am J Physiol (1980) 0.77
[Reversible spinal cord compression caused by extramedullary hematopoietic foci in thalassemia]. Dtsch Med Wochenschr (1993) 0.77
[Is hemofiltration following acute kidney failure in elderly cardiovascular surgery patients justified?]. Schweiz Med Wochenschr (1997) 0.77
Preclinical studies on the use of selective antibody-ricin conjugates in autologous bone marrow transplantation. Blood (1985) 0.76
Randomized trial of conversion from mycophenolate mofetil to azathioprine 6 months after renal allograft transplantation. Nephrol Dial Transplant (2000) 0.76
Pneumocystis carinii pneumonia during immunosuppressive therapy for antineutrophil cytoplasmic autoantibody-positive vasculitis. Arch Intern Med (1995) 0.76
[Successful allotransplantation of an island of Langerhans]. Schweiz Med Wochenschr (1979) 0.76
Postmarketing evaluation of mycophenolate mofetil-based triple therapy immunosuppression compared with a conventional azathioprine-based regimen reveals enhanced efficacy and early pharmacoeconomic benefit after renal transplantation. Transplant Proc (1998) 0.76
"Hypoparathyroidism", hyperostosis, normophosphataemia and thyrocalcitonin. A possible case of hyperthyrocalcitoninism. Acta Endocrinol (Copenh) (1967) 0.76
Letter: Treatment of herpes infection with human exogenous interferon. Lancet (1975) 0.76
Calcium transport in the ileum of uremic rats. Am J Physiol (1982) 0.76
Rapidity of plasma 1,25-dihydroxyvitamin D responses to hypo- and hypercalcemia in steers. Endocrinology (1983) 0.76
[Oral medication of iron: tolerance for iron sulphate and iron sulphate plus succinic acid, influence on haemoglobin concentration of healthy subjects (author's transl)]. Dtsch Med Wochenschr (1974) 0.76
Effects of calcium intake and renal function on plasma immunoreactive parathyroid hormone levels in rats. Horm Metab Res (1978) 0.75
Effects of platelet activating factor (PAF) on human citrated whole blood. Eur J Haematol (1988) 0.75
[Macroamylase as a rare cause of hyperamylasemia]. Klin Wochenschr (1972) 0.75
Regulation of circulating parathyroid hormone levels: normal physiology and consequences in disorders of mineral metabolism. Klin Wochenschr (1975) 0.75
Pharmacokinetics of cefotiam and cefsulodin after simultaneous administration to patients with impaired renal function. Antimicrob Agents Chemother (1984) 0.75
Serum hippuric acid concentration in renal allograft rejection, ureter obstruction, and tubular necrosis. Transpl Int (1994) 0.75
[Variation of morphometric measurements in bone biopsies (author's transl)]. Microsc Acta (1977) 0.75
[Ionised calcium in the course of hemodialysis treatment]. Klin Wochenschr (1972) 0.75
Calcium metabolism and kidney disease. Ergeb Inn Med Kinderheilkd (1974) 0.75
Normocalcemic secondary hyperparathyroidism and malabsorption. Helv Med Acta (1969) 0.75
[Metabolically conditioned erythrocyte rigidity in hemodialyzed uremic patients]. Schweiz Med Wochenschr (1974) 0.75
[Acute kidney failure as a complication of fasting therapy]. Schweiz Med Wochenschr (1977) 0.75
Fractional intestinal calcium absorption in azotemic rats in vivo. Res Exp Med (Berl) (1972) 0.75
[The effect of propranolol on basal and stimulated renin activity in patients with kidney transplantation]. Verh Dtsch Ges Inn Med (1976) 0.75
[10 years survival of kidney grafts]. Schweiz Med Wochenschr (1977) 0.75
[Proceedings: Relationship between immunoreactive parathormone and serum calcium concentration in primary hyperparathyroidism]. Helv Med Acta (1974) 0.75
[Histomorphometric evaluation of bone biopsies; comparison of two methods (author's transl)]. Microsc Acta (1976) 0.75
[Treatment of uremic sympathicopathy with levodopa]. Schweiz Med Wochenschr (1977) 0.75
[Clinical disorders of potassium metabolism]. Schweiz Med Wochenschr (1977) 0.75